Skip to main content
Premium Trial:

Request an Annual Quote

ParAllele BioScience, Invitrogen, Applied Biosystems


ParAllele BioScience has launched a 10,000-SNP, 8,000-gene MegAllele panel for use in human genotyping studies, the company said this week. The panel represents "most of the major drug target gene families," and is available through ParAllele's genotyping service, later to be developed by Affymetrix and ParAllele for commercial release, the company said. The commercial assay will run on Affymetrix's GeneChip 3000 platform, the company added.

Invitrogen is offering a discount of 50 percent off the price of many of its nucleic-acid purification products on its website, the company said last week. The selected products includes several genomic DNA, plasmid DNA, plant DNA, total RNA, mRNA, and microRNA purification kits, in addition to seven magnetic separator models.

Applied Biosystems introduced a program to encourage service providers to use its Expression Array System and TaqMan assays, the company said last week. The company said it is offering a product bundle around its Expression Array System, as well as technical and promotional support, and options for including additions products such as TaqMan assays and RT-PCR systems.

Filed under

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.